News
-
Future viability of the PBS
Tuesday | Dec 3 2013Medicines Australia ceo Brendan Shaw has focused the organisation’s submission to the National Commission of Audit.
-
GMiA slams Grattan jibe
Tuesday | Dec 3 2013Kate Lynch, ceo of the Generic Medicines Industry Association, has roundly criticised the Grattan Institute’s assertion.
-
New orphan drug
Tuesday | Dec 3 2013The Therapeutic Goods Administration has added Amgen Australia’s blinatumomab (powder for reconstitution, injection) to its list.
-
‘Quit Wave’ tsunami
Tuesday | Dec 3 201347 per cent of Australia’s 2.8 million smokers are more likely to consider a quit attempt.
-
Takeda appointment
Tuesday | Dec 3 2013Japanese pharmaceutical giant Takeda has appointed Christophe Weber as its chief operating officer, with plans to.
-
Relativity sheets
Tuesday | Dec 3 2013THE Department of Health has updated its Therapeutic Relativity Sheets reflecting changes which came into effect.
-
Universal PCEHR – CHF
Monday | Dec 2 2013The Consumers Health Forum (CHF) is calling upon the federal government to adopt a more proactive.
-
OxyELITE Pro alert
Monday | Dec 2 2013The TGA has warned that OxyELITE Pro capsules contain the prohibited substance yohimbine (PD 12 July).
-
GSK Panadol recall
Monday | Dec 2 2013Glaxosmithkline this morning announced the immediate recall of two batches of Children’s Panadol 1-5 years Suspension.
-
Price disclosure “failing”
Monday | Dec 2 2013Australian consumers are still paying way too much for PBS medications, despite the latest cuts due.